Pykus Therapeutics, Inc. — Form D
Pykus Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-05. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-02-05
- Form: D
- Accession: 0001840955-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 32
- Date of first sale: 2020-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-388583
Issuer
- Name: Pykus Therapeutics, Inc.
- CIK: 0001840955
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: ONE MIFFLIN PLACE, SUITE 320, CAMBRIDGE, MA, 02138
- Phone: 617-394-8960
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Carl A Berke | Director | Cambridge, MA |
| Richel P Liu | Director | Cambridge, MA |
| Sameer P Sabir | Director | Cambridge, MA |
| Michael A Singer | Director | Cambridge, MA |
| Thomas P Stryjewski | Director | Cambridge, MA |
| James A Stefater | Executive Officer | Cambridge, MA |
More